Ulland Tyler K, Ferguson Polly J, Sutterwala Fayyaz S
J Clin Invest. 2015 Feb;125(2):469-77. doi: 10.1172/JCI75254. Epub 2015 Feb 2.
Activation of the inflammasome occurs in response to infection with a wide array of pathogenic microbes. The inflammasome serves as a platform to activate caspase-1, which results in the subsequent processing and secretion of the proinflammatory cytokines IL-1β and IL-18 and the initiation of an inflammatory cell death pathway termed pyroptosis. Effective inflammasome activation is essential in controlling pathogen replication as well as initiating adaptive immune responses against the offending pathogens. However, a number of pathogens have developed strategies to evade inflammasome activation. In this Review, we discuss these pathogen evasion strategies as well as the potential infectious complications of therapeutic blockade of IL-1 pathways.
炎性小体的激活发生在对多种致病微生物感染的反应中。炎性小体作为激活半胱天冬酶 -1的平台,这导致促炎细胞因子IL-1β和IL-18的后续加工和分泌,并启动一种称为细胞焦亡的炎性细胞死亡途径。有效的炎性小体激活对于控制病原体复制以及启动针对有害病原体的适应性免疫反应至关重要。然而,许多病原体已经开发出逃避炎性小体激活的策略。在本综述中,我们讨论了这些病原体逃避策略以及IL-1途径治疗性阻断的潜在感染性并发症。